Biolase, Inc. (BIOLQ) vs ThermoGenesis Holdings, Inc. (THMO)
Biolase, Inc. and ThermoGenesis Holdings, Inc. are both Medical Devices companies. Biolase, Inc. is the larger, with a market value of $2.3M against $1.1M — 2.1× the size. Biolase, Inc. grew revenue faster over the last twelve months: −7.44% against −7.53%. Biolase, Inc. has the higher net margin (−71.8% vs −153.4%) and the lower return on invested capital (−109.5% vs 0.00%). Across the 14 metrics below, Biolase, Inc. leads on 10 and ThermoGenesis Holdings, Inc. on 4.
Valuation
Profitability
| Metric | BIOLQ | THMO | Medical Devices median |
|---|---|---|---|
| Gross margin | 34.44% | 21.10% | 56.01% |
| Operating margin | (29.37%) | (84.52%) | (15.03%) |
| Net margin | (71.75%) | (153.43%) | (20.40%) |
| Free cash flow margin | (28.55%) | (47.79%) | (7.24%) |
| Return on equity | 1,349.30% | (751.34%) | (15.32%) |
| Return on assets | (100.09%) | (98.83%) | (19.72%) |
| Return on invested capital | (109.48%) | 0.00% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack